Cargando…
Propensity-score-matching analysis to compare efficacy and safety between 16-gauge and 18-gauge needle in ultrasound-guided biopsy for peripheral pulmonary lesions
BACKGROUND: Definitive diagnosis of peripheral pulmonary lesions (PPLs) depends on the histological analysis of the pleural biopsy sample. Ultrasound (US)-guided sampling is now standard practice in the clinical setting. However, determining a suitable needle size and sampling times to improve the e...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034192/ https://www.ncbi.nlm.nih.gov/pubmed/33836683 http://dx.doi.org/10.1186/s12885-021-08126-7 |
_version_ | 1783676501591326720 |
---|---|
author | Huang, Weijun Ye, Jieyi Qiu, Yide Peng, Weiwei Lan, Ninghui Cui, Weizhen Huang, Ting Ou, Yinghui Li, Yingjia |
author_facet | Huang, Weijun Ye, Jieyi Qiu, Yide Peng, Weiwei Lan, Ninghui Cui, Weizhen Huang, Ting Ou, Yinghui Li, Yingjia |
author_sort | Huang, Weijun |
collection | PubMed |
description | BACKGROUND: Definitive diagnosis of peripheral pulmonary lesions (PPLs) depends on the histological analysis of the pleural biopsy sample. Ultrasound (US)-guided sampling is now standard practice in the clinical setting. However, determining a suitable needle size and sampling times to improve the efficacy and safety of the biopsy remains challenging. Here, we compared the efficacy between 16- and 18-gauge core biopsy needles in US-guided percutaneous transthoracic biopsy for PPLs on histological diagnosis and procedure-related complications. MATERIALS AND METHODS: In total, 1169 patients (767 men, 402 women; mean age, 59.4 ± 13.2 years) who received biopsy for PPLs between September 2011 and February 2019 were included. The propensity score matching (PSM) analysis was performed to adjust the baseline differences, and the rate of successful specimen assessment and complications were compared between the 16-gauge (249 patients) and 18-gauge (920 patients) groups. The number of pleural surfaces crossed (NOPSC) was defined as the number of times the visceral pleural surface was transgressed. Stratified analysis was performed based on NOPSC. RESULTS: The overall success rate was 92.0% (1076/1169). The overall complication rate was 9.6%, including pneumothorax, hemorrhage, and vasovagal reaction, which occurred in 2.5% (29/1169), 6.6% (77/1169), and 0.5% (6/1169) of the patients, respectively. When NOPSC was 1 or > 2, the success and complication rates in the 16-gauge group were comparable to those of the 18-gauge group (all P > 0.05). When the NOPSC was 2, the success rate in the 16-gauge group was significantly higher than that in the 18-gauge group (P = 0.017), whereas the complication rate was comparable (P > 0.05). CONCLUSION: Higher success rate could be achieved using a 16-gauge than an 18-gauge core biopsy needle in the US-guided percutaneous transthoracic biopsy for PPLs when the NOPSC was 2. We recommend using 16-gauge needles with 2 times of needle passes in biopsy for PPLs in clinical practice. |
format | Online Article Text |
id | pubmed-8034192 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80341922021-04-12 Propensity-score-matching analysis to compare efficacy and safety between 16-gauge and 18-gauge needle in ultrasound-guided biopsy for peripheral pulmonary lesions Huang, Weijun Ye, Jieyi Qiu, Yide Peng, Weiwei Lan, Ninghui Cui, Weizhen Huang, Ting Ou, Yinghui Li, Yingjia BMC Cancer Research Article BACKGROUND: Definitive diagnosis of peripheral pulmonary lesions (PPLs) depends on the histological analysis of the pleural biopsy sample. Ultrasound (US)-guided sampling is now standard practice in the clinical setting. However, determining a suitable needle size and sampling times to improve the efficacy and safety of the biopsy remains challenging. Here, we compared the efficacy between 16- and 18-gauge core biopsy needles in US-guided percutaneous transthoracic biopsy for PPLs on histological diagnosis and procedure-related complications. MATERIALS AND METHODS: In total, 1169 patients (767 men, 402 women; mean age, 59.4 ± 13.2 years) who received biopsy for PPLs between September 2011 and February 2019 were included. The propensity score matching (PSM) analysis was performed to adjust the baseline differences, and the rate of successful specimen assessment and complications were compared between the 16-gauge (249 patients) and 18-gauge (920 patients) groups. The number of pleural surfaces crossed (NOPSC) was defined as the number of times the visceral pleural surface was transgressed. Stratified analysis was performed based on NOPSC. RESULTS: The overall success rate was 92.0% (1076/1169). The overall complication rate was 9.6%, including pneumothorax, hemorrhage, and vasovagal reaction, which occurred in 2.5% (29/1169), 6.6% (77/1169), and 0.5% (6/1169) of the patients, respectively. When NOPSC was 1 or > 2, the success and complication rates in the 16-gauge group were comparable to those of the 18-gauge group (all P > 0.05). When the NOPSC was 2, the success rate in the 16-gauge group was significantly higher than that in the 18-gauge group (P = 0.017), whereas the complication rate was comparable (P > 0.05). CONCLUSION: Higher success rate could be achieved using a 16-gauge than an 18-gauge core biopsy needle in the US-guided percutaneous transthoracic biopsy for PPLs when the NOPSC was 2. We recommend using 16-gauge needles with 2 times of needle passes in biopsy for PPLs in clinical practice. BioMed Central 2021-04-09 /pmc/articles/PMC8034192/ /pubmed/33836683 http://dx.doi.org/10.1186/s12885-021-08126-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Huang, Weijun Ye, Jieyi Qiu, Yide Peng, Weiwei Lan, Ninghui Cui, Weizhen Huang, Ting Ou, Yinghui Li, Yingjia Propensity-score-matching analysis to compare efficacy and safety between 16-gauge and 18-gauge needle in ultrasound-guided biopsy for peripheral pulmonary lesions |
title | Propensity-score-matching analysis to compare efficacy and safety between 16-gauge and 18-gauge needle in ultrasound-guided biopsy for peripheral pulmonary lesions |
title_full | Propensity-score-matching analysis to compare efficacy and safety between 16-gauge and 18-gauge needle in ultrasound-guided biopsy for peripheral pulmonary lesions |
title_fullStr | Propensity-score-matching analysis to compare efficacy and safety between 16-gauge and 18-gauge needle in ultrasound-guided biopsy for peripheral pulmonary lesions |
title_full_unstemmed | Propensity-score-matching analysis to compare efficacy and safety between 16-gauge and 18-gauge needle in ultrasound-guided biopsy for peripheral pulmonary lesions |
title_short | Propensity-score-matching analysis to compare efficacy and safety between 16-gauge and 18-gauge needle in ultrasound-guided biopsy for peripheral pulmonary lesions |
title_sort | propensity-score-matching analysis to compare efficacy and safety between 16-gauge and 18-gauge needle in ultrasound-guided biopsy for peripheral pulmonary lesions |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034192/ https://www.ncbi.nlm.nih.gov/pubmed/33836683 http://dx.doi.org/10.1186/s12885-021-08126-7 |
work_keys_str_mv | AT huangweijun propensityscorematchinganalysistocompareefficacyandsafetybetween16gaugeand18gaugeneedleinultrasoundguidedbiopsyforperipheralpulmonarylesions AT yejieyi propensityscorematchinganalysistocompareefficacyandsafetybetween16gaugeand18gaugeneedleinultrasoundguidedbiopsyforperipheralpulmonarylesions AT qiuyide propensityscorematchinganalysistocompareefficacyandsafetybetween16gaugeand18gaugeneedleinultrasoundguidedbiopsyforperipheralpulmonarylesions AT pengweiwei propensityscorematchinganalysistocompareefficacyandsafetybetween16gaugeand18gaugeneedleinultrasoundguidedbiopsyforperipheralpulmonarylesions AT lanninghui propensityscorematchinganalysistocompareefficacyandsafetybetween16gaugeand18gaugeneedleinultrasoundguidedbiopsyforperipheralpulmonarylesions AT cuiweizhen propensityscorematchinganalysistocompareefficacyandsafetybetween16gaugeand18gaugeneedleinultrasoundguidedbiopsyforperipheralpulmonarylesions AT huangting propensityscorematchinganalysistocompareefficacyandsafetybetween16gaugeand18gaugeneedleinultrasoundguidedbiopsyforperipheralpulmonarylesions AT ouyinghui propensityscorematchinganalysistocompareefficacyandsafetybetween16gaugeand18gaugeneedleinultrasoundguidedbiopsyforperipheralpulmonarylesions AT liyingjia propensityscorematchinganalysistocompareefficacyandsafetybetween16gaugeand18gaugeneedleinultrasoundguidedbiopsyforperipheralpulmonarylesions |